Reversing the risk: It’s time to adopt structured content authoring
To automate content development, pharmaceutical companies must move to structured content authoring.
Single-source publishing to multiple outputs for Pharma
In pharma, some digital marketing teams have embraced multi-channel publishing as a way to meet regulatory requirements.
Pharma labeling: A paragon of content reuse
Because labeling is global and requires localization, pharma companies gain even more benefit from content reuse.
Getting Granular with eCTD v4.0
We talk a lot about the goal of enterprise content strategy for pharma: to help speed up the process of making safe, effective medicines. One part of achieving that goal is to get content through regulatory approval faster. To speed up review and approval, pharma...
Solving the XML Authoring Conundrum for Pharma
“We cannot change the authoring experience.” This, more than anything else, is the message we used to be told (and still hear often) when we suggest a component-based structured authoring environment for medical writers at pharmaceutical companies. The authoring...
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.